MNKD

MannKind Corporation Healthcare - Biotechnology Investor Relations →

YES
39.0% BELOW
↑ Moving away Was -42.1% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $4.65
14-Week RSI 24 📉
Rel. Volume (14w) This week's trading vs. the 14-week average 0.8x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.63 — Sellers winning

MannKind Corporation (MNKD) closed at $2.84 as of 2026-05-01, trading 39.0% below its 200-week moving average of $4.65. This places MNKD in the extreme value zone. The stock moved further from the line this week, up from -42.1% last week. With a 14-week RSI of 24, MNKD is in oversold territory.

Over the past 14 weeks, down-weeks have had more trading volume than up-weeks (0.63 buyers-vs-sellers ratio). That means when people are active, they're more often selling than buying. Sellers are still more in control than buyers.

Over the past 1087 weeks of data, MNKD has crossed below its 200-week moving average 12 times. On average, these episodes lasted 54 weeks. The average one-year return after crossing below was -9.0%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $877 million, MNKD is a small-cap stock. The company generates a free cash flow yield of 4.1%. The stock trades at -17.1x book value.

Share count has increased 16.7% over three years, indicating dilution.

Over the past 20.8 years, a hypothetical investment of $100 in MNKD would have grown to $7, compared to $852 for the S&P 500. MNKD has returned -12.2% annualized vs 10.8% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: MNKD vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After MNKD Crosses Below the Line?

Across 12 historical episodes, buying MNKD when it crossed below its 200-week moving average produced an average return of -13.7% after 12 months (median -43.0%), compared to +13.9% for the S&P 500 over the same periods. 30% of those episodes were profitable after one year. After 24 months, the average return was -39.7% vs +21.9% for the index.

Each line shows $100 invested at the moment MNKD crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

MNKD has crossed below its 200-week MA 12 times with an average 1-year return of +-9.0% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jul 2005Jan 20062739.6%+94.8%-94.8%
Mar 2007Jan 201014984.9%-64.5%-96.4%
Feb 2010Feb 201018.9%-41.1%-93.5%
Mar 2010Dec 20103843.5%-50.1%-92.1%
Jan 2011May 201312168.5%-51.0%-90.1%
Apr 2015May 2015416.5%-67.7%-86.4%
Jul 2015Sep 202026895.9%-76.9%-86.8%
Nov 2023Nov 202314.6%+114.3%-17.2%
Dec 2023Feb 20241212.1%+89.9%-20.7%
Apr 2025Apr 202510.4%-37.4%-37.4%
May 2025Aug 20251522.1%N/A-35.0%
Feb 2026Ongoing10+51.4%Ongoing-13.4%
Average54+-9.0%

Frequently Asked Questions

Is MNKD below its 200-week moving average?

Yes. As of 2026-05-01, MannKind Corporation (MNKD) is trading 39.0% below its 200-week moving average of $4.65. The current price is $2.84.

What is MNKD's 200-week moving average price?

MannKind Corporation's 200-week moving average is $4.65 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when MNKD drops below its 200-week moving average?

MNKD has crossed below its 200-week moving average 12 times in our data. The average one-year return after these crossings was -9.0%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 54 weeks on average.

Is MNKD a good value right now?

Here's what our data says about MNKD as of 2026-05-01: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 24 (oversold). Free cash flow yield is 4.1%. Price-to-book is -17.1x. This is not a buy or sell recommendation — always do your own research.

How does MNKD compare to the S&P 500?

Over the past 20.8 years, $100 invested in MNKD would have grown to $7, compared to $852 for the S&P 500. That's -12.2% annualized vs 10.8% for the index. MNKD has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-05-01